CMR Surgical CEO Bose steps down
Massimiliano Colella, who joined the surgical robotics firm in late 2023, was named interim CEO.
Uncategorized
Shiratronics raises $66M for trial of neuromodulation migraine device
The funding will support the trial, premarket approval application and initial commercial launch of a system that could interrupt or change the transmission of pain signals to the brain.
Shiratronics raises $66M for trial of neuromodulation migraine device Read More »
UnitedHealth, CVS push to remove FTC Chair Lina Khan from PBM case
Attorneys argue Khan and two other commissioners are biased against pharmacy benefit managers and should recuse themselves from an ongoing lawsuit against the middlemen.
UnitedHealth, CVS push to remove FTC Chair Lina Khan from PBM case Read More »
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan Read More »
Gritstone Files for Bankruptcy in Effort to Save Clinical Research
Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the company hopes will save its clinical research in cancer and infectious disease.
Gritstone Files for Bankruptcy in Effort to Save Clinical Research Read More »
Dr. Cervilla, la cara visible de la Blefaroplastia en Sevilla
En la búsqueda de una apariencia más joven y fresca, la blefaroplastia se ha convertido en una tendencia tanto estéticamente atractiva como culturalmente relevante. Esta intervención quirúrgica gana popularidad entre toda la población que busca rejuvenecer s …
Dr. Cervilla, la cara visible de la Blefaroplastia en Sevilla Read More »
Pfizer Phase III Prostate Cancer Win Builds Case for Broader Label for Talzenna-Xtandi Combo
The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, potentially covering all patients with metastatic castration-resistant prostate cancer regardless of biomarker status.
El papel clave de los estudiantes brasileños en las colaboraciones científicas internacionales
La globalización ha transformado la forma en que se conducen las investigaciones científicas. Por esta razón, el intercambio de información y el acceso a redes colaborativas se ha hecho más fácil. Además, las plataformas digitales permiten e …
How AI Could Ease Tension in Clinical Trials
In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on AI and the opportunity in patient lives.
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer. Analysts say separate concerns remain about its vaccines business.
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines Read More »